Literature DB >> 24051118

Minimal clinically significant change for the International Restless Legs Syndrome Study Group rating scale in clinical trials is a score of 3.

Richard P Allen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24051118     DOI： 10.1016/j.sleep.2013.08.001

Source DB:  PubMed          Journal:  Sleep Med        ISSN： 1389-9457            Impact factor:   3.492


× No keyword cloud information.
  11 in total

1.  Decreased Symptoms without Augmented Skin Blood Flow in Subjects with RLS/WED after Vibration Treatment.

Authors:  Ulrike H Mitchell; Sterling C Hilton; Erik Hunsaker; Jan Ulfberg
Journal:  J Clin Sleep Med       Date:  2016-07-15       Impact factor: 4.062

2.  The DIalysis Symptom COntrol-Restless Legs Syndrome (DISCO-RLS) Trial: A Protocol for a Randomized, Crossover, Placebo-Controlled Blinded Trial.

Authors:  David Collister; Kayla Pohl; Gwen Herrington; Shun Fu Lee; Christian Rabbat; Karthik Tennankore; Deborah Zimmermann; Navdeep Tangri; Ron Wald; Braden Manns; Rita S Suri; Annie-Claire Nadeau-Fredette; Remi Goupil; Samuel A Silver; Michael Walsh
Journal:  Can J Kidney Health Dis       Date:  2020-11-26

3.  Effect of Near-Infrared Light Therapy Based on Acupoints on the Severity of Restless Legs Syndrome in Patients Undergoing Hemodialysis: A Single-Blind, Randomized Controlled Trial.

Authors:  Mohammad Mehdi Mohammadi; Ali Akbar Vaisi Raygani; Akram Ghobadi; Soheila Samadzadeh; Nader Salari
Journal:  Clin Med Res       Date:  2018-05-18

4.  Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease).

Authors:  William G Ondo; Frank Grieger; Kimberly Moran; Ralf Kohnen; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2016-01       Impact factor: 4.062

5.  Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  John W Winkelman; Melissa J Armstrong; Richard P Allen; K Ray Chaudhuri; William Ondo; Claudia Trenkwalder; Phyllis C Zee; Gary S Gronseth; David Gloss; Theresa Zesiewicz
Journal:  Neurology       Date:  2016-11-16       Impact factor: 9.910

6.  Effect of Aerobic Exercise on Dialysis-Related Symptoms in Individuals Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis of Clinical Trials.

Authors:  Nicholas Hargrove; Nada El Tobgy; Olivia Zhou; Mark Pinder; Brittany Plant; Nicole Askin; Laura Bieber; David Collister; Reid Whitlock; Navdeep Tangri; Clara Bohm
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-25       Impact factor: 8.237

7.  Feasibility and efficacy of a physical activity intervention for managing restless legs syndrome in multiple sclerosis: Results of a pilot randomized controlled trial.

Authors:  Katie L J Cederberg; Robert W Motl
Journal:  Mult Scler Relat Disord       Date:  2021-02-10       Impact factor: 4.339

8.  Noninvasive neuromodulation reduces symptoms of restless legs syndrome.

Authors:  Mark J Buchfuhrer; Fiona C Baker; Haramandeep Singh; Viktoriia Kolotovska; Bahman Adlou; Harnadar Anand; Massimiliano de Zambotti; Mehvish Ismail; Shriram Raghunathan; Jonathan D Charlesworth
Journal:  J Clin Sleep Med       Date:  2021-08-01       Impact factor: 4.324

9.  Restless legs syndrome severity in the National RLS Opioid Registry during the COVID-19 pandemic.

Authors:  Benjamin Wipper; Christopher Romero-Gutierrez; John W Winkelman
Journal:  Sleep Med       Date:  2022-01-23       Impact factor: 3.492

10.  Iron for the treatment of restless legs syndrome.

Authors:  Lynn M Trotti; Lorne A Becker
Journal:  Cochrane Database Syst Rev       Date:  2019-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.